Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial | American Journal of Psychiatry March 25, 2018Dr. Joris Wiggers https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2017.17030325 Share this:TwitterFacebookLike this:Like Loading... Related